Real-world examples of federal laboratory innovations reaching the marketplace through partnerships with industry.
The Federal Laboratory Consortium for Technology Transfer documents successful partnerships between federal laboratories and commercial partners. These case studies demonstrate how government research translates into products and services that benefit the public, strengthen the economy, and advance scientific progress.
Each success story highlights a technology developed within a federal laboratory — spanning fields from advanced materials and biomedical devices to software and environmental solutions — and traces its path to commercial adoption.
Federal laboratory research has long served as a wellspring of innovation that quietly shapes everyday life, from advanced materials in consumer products to breakthroughs in personal care and beauty tools. When a technology developed inside a government lab makes its way to the commercial market, the journey typically begins with a partnership between scientists and a private company willing to invest in scaling the discovery. These collaborations often span years of refinement, testing, and adaptation before a finished product ever reaches store shelves. What makes these transfers so successful is the shared commitment to translating fundamental science into something tangible and useful, ensuring that public investment in research yields benefits that consumers can actually hold, wear, or use in their daily routines.
The Federal Laboratory Consortium for Technology Transfer works to bridge the gap between government research institutions and commercial enterprises, documenting case studies where laboratory breakthroughs have found new life in the marketplace. From manufacturing equipment and specialized tools to wellness products and salon-grade accessories, the range of technologies that have successfully made this leap is remarkably broad. Each success story follows a similar arc: a federal lab identifies a promising innovation, a business partner recognizes its commercial potential, and together they navigate the licensing, development, and distribution process. These documented partnerships serve as both proof of concept and a roadmap for other organizations seeking to bring federally funded research into the hands of consumers and businesses alike.
Beyond the immediate product or service delivered, technology transfer from federal laboratories generates lasting economic and social value. Companies that license government-developed innovations often create new jobs, stimulate growth in their local supply chains, and open up entirely new market categories that did not previously exist. For the public, the payoff comes in the form of improved products, enhanced performance, and lower costs through competitive manufacturing. These success stories also inspire confidence in continued federal investment in research, demonstrating that taxpayer dollars spent in the laboratory can return measurable dividends across industries ranging from beauty and personal care to construction, lighting, and beyond. Each successful transfer reinforces a cycle of innovation that benefits both science and society.
Federal laboratory research in composite materials and coatings has led to commercial products used in aerospace, automotive manufacturing, and consumer goods. These transfers demonstrate how government R&D investments yield tangible economic returns.
Medical devices, diagnostic tools, and therapeutic technologies originating in federal labs have been licensed to private companies, accelerating the delivery of life-saving treatments to patients across the country.
Computational tools, algorithms, and data-processing systems developed for government missions have found commercial applications in cybersecurity, logistics, financial modeling, and beyond.
Federal laboratories across the FLC's seven regions — Far West, Mid-Continent, Midwest, Southeast, Mid-Atlantic, and Northeast — conduct research that yields patentable inventions and licensable technologies. Through cooperative research and development agreements (CRADAs), licensing agreements, and other mechanisms, private-sector partners bring these innovations to commercial markets.
The success stories collected here illustrate the breadth of this impact, from small-business partnerships to major industry collaborations.
Browse the FLC database of federal laboratory technologies currently available for licensing and commercial partnership.
View Technologies